Skip to main content
Institutional deep-dive - valuation, health, statements

Financial Analysis

Filing-based analysis. Market pricing is not included. Fundamentals from SEC filings; economic data from FRED and the BLS. About our data

Fundamentals

Benitec Biopharma Inc. BNTC

· Materials · Pharmaceutical Preparations

FY2021 10-K, filed 2021-09-20
SEC EDGAR

Filing evidence summary

Caution evidenceCoverage 4/5 core metrics

Latest reported annual revenue changed -42.2% from the prior reported annual observation.

Backward-looking filed evidence under visible rules - not a rating, forecast or investment advice. Missing data is never scored.

Evidence signals

  • Revenue contracted

    Latest reported annual revenue changed -42.2% from the prior reported annual observation.

    Why this surfaced

    Direction threshold: above +2% constructive; below -2% caution; otherwise monitor. This is not labeled one-year growth when filing periods have a gap. Period end 2021-06-30.

  • Operating margin compressed

    Operating margin changed -14925.4 percentage points from the prior annual period.

    Why this surfaced

    Direction threshold: more than +1 percentage point constructive; below -1 point caution. Period end 2021-06-30.

  • Free cash flow was negative

    Latest reported free cash flow was -$17M.

    Why this surfaced

    Free cash flow = operating cash flow minus capital expenditures; positive is supporting evidence, not a valuation conclusion. Period end 2026-06-30.

  • 2 filing risk checks flagged

    Flagged areas: Dilution.

    Why this surfaced

    The full financial analysis shows each value, threshold, and sector limitation.

Core trend metrics

Latest annual revenue growth
-42.2%
as of 2021-06-30
Latest annual operating margin
-23044.1%
as of 2021-06-30
Free cash flow
-$17M
as of 2026-06-30
ROIC snapshot
-22.1%
period varies

Hover a tile for its exact definition; the Statements tab carries per-cell filing citations.

Where to look next

Risk checks

2of 6 rule-based checks flagged
  • Dilution

Financial movement

  • Cash→ flat
  • Long-term debt→ flat
  • Inventory→ flat
  • Receivables→ flat
  • Current assets→ flat

Source & freshness

Source
SEC EDGAR XBRL
Fetched
2026-09-19
Latest period end
2026-06-30
Filings
EDGAR ↗

Reported segment mix

Not available for BNTC: no dimensional revenue or operating-income facts for this filer in the ingested DERA files (segment, product/service, geography axes). Missing is not zero - a filer that reports one segment simply has no split to show.

Peer percentiles

latest fiscal year ending 2026-06-30 · among 4,082 US-listed filers · 793 in Materials
MetricValuevs all filersvs sector
Return on equity
net income ÷ stockholders' equity (positive equity only)
-25.7%
26thof 3,531
bottom third
57thof 693
middle third
Cash-flow accrual ratio
(net income − operating cash flow) ÷ average total assets · lower is ranked higher
-20.6%
88thof 3,871
top third
81stof 758
top third
Balance-sheet accrual ratio
change in net operating assets ÷ average net operating assets · lower is ranked higher
147.3%
8thof 3,318
bottom third
13thof 666
bottom third

Each filer's latest fiscal year as stored by the nightly crawl; fiscal year ends differ across the universe. A metric ranks only filers for which it is computable from filed facts. Ties split; a rank reads "better than N% of filers" in the metric's own direction. Descriptive and educational, not a rating.

Earnings quality

latest fiscal year ending 2026-06-30 · accruals and cash conversion as filed
Cash conversion
-
operating cash flow ÷ net income, latest fiscal year
Cash-flow accrual ratio
-20.6%
(net income − operating cash flow) ÷ average total assets
Balance-sheet accrual ratio
147.3%
change in net operating assets ÷ average net operating assets
Cash-backed years
4 of 4
fiscal years where operating cash flow met or exceeded net income
Mean cash conversion
-
across the stored fiscal years with positive net income

Per fiscal year from filed facts: cash conversion = operating cash flow / net income (net income > 0); cash-flow accrual ratio = (net income - operating cash flow) / average total assets; balance-sheet accrual ratio = change in net operating assets / average net operating assets, NOA = (assets - cash) - (liabilities - debt). Descriptive; a missing input yields a missing ratio. High accrual ratios and cash conversion well below one are the measures the accruals literature associates with less persistent earnings; they are screens to read the cash-flow statement with, not conclusions. The per-year series is part of Pro risk analysis.

Point-in-time ledger

first-reported vs latest filing · periods since 2020-01-01 · 18 changed periods
Line itemPeriodFirst reportedLatest filingChangeFilings
Diluted shares
WeightedAverageNumberOfDilutedSharesOutstanding
fiscal year 2024-06-304,060,182 shares
10-K 2024-09-26
18,364,386 shares
10-K/A 2026-03-20
+352.3%first · latest · 3 filings carry it
Basic shares
WeightedAverageNumberOfSharesOutstandingBasic
fiscal year 2024-06-304,060,182 shares
10-K 2024-09-26
18,364,386 shares
10-K/A 2026-03-20
+352.3%first · latest · 3 filings carry it
Diluted shares
WeightedAverageNumberOfDilutedSharesOutstanding
quarter 2024-09-3010,644,533 shares
10-Q 2024-11-14
27,883,624 shares
10-K/A 2026-03-20
+161.9%first · latest · 4 filings carry it
Basic shares
WeightedAverageNumberOfSharesOutstandingBasic
quarter 2024-09-3010,644,533 shares
10-Q 2024-11-14
27,883,624 shares
10-K/A 2026-03-20
+161.9%first · latest · 4 filings carry it
Diluted shares
WeightedAverageNumberOfDilutedSharesOutstanding
fiscal year 2022-06-308,171,690 shares
10-K 2022-09-02
480,688 shares
10-K 2023-09-21
-94.1%first · latest
Diluted shares
WeightedAverageNumberOfDilutedSharesOutstanding
quarter 2022-09-3010,855,710 shares
10-Q 2022-11-10
638,572 shares
10-Q 2023-11-13
-94.1%first · latest
Diluted shares
WeightedAverageNumberOfDilutedSharesOutstanding
quarter 2022-12-3127,561,766 shares
10-Q 2023-02-13
1,621,280 shares
10-Q 2024-02-13
-94.1%first · latest
Diluted shares
WeightedAverageNumberOfDilutedSharesOutstanding
quarter 2023-03-3127,981,161 shares
10-Q 2023-05-15
1,645,951 shares
10-Q 2024-05-13
-94.1%first · latest
Basic shares
WeightedAverageNumberOfSharesOutstandingBasic
fiscal year 2022-06-308,171,690 shares
10-K 2022-09-02
480,688 shares
10-K 2023-09-21
-94.1%first · latest
Basic shares
WeightedAverageNumberOfSharesOutstandingBasic
quarter 2022-09-3010,855,710 shares
10-Q 2022-11-10
638,572 shares
10-Q 2023-11-13
-94.1%first · latest
Basic shares
WeightedAverageNumberOfSharesOutstandingBasic
quarter 2022-12-3127,561,766 shares
10-Q 2023-02-13
1,621,280 shares
10-Q 2024-02-13
-94.1%first · latest
Basic shares
WeightedAverageNumberOfSharesOutstandingBasic
quarter 2023-03-3127,981,161 shares
10-Q 2023-05-15
1,645,951 shares
10-Q 2024-05-13
-94.1%first · latest
Diluted shares
WeightedAverageNumberOfDilutedSharesOutstanding
quarter 2024-12-3122,075,332 shares
10-Q 2025-02-14
37,254,839 shares
10-Q 2026-02-12
+68.8%first · latest
Basic shares
WeightedAverageNumberOfSharesOutstandingBasic
quarter 2024-12-3122,075,332 shares
10-Q 2025-02-14
37,254,839 shares
10-Q 2026-02-12
+68.8%first · latest
Net income
NetIncomeLoss
quarter 2025-03-31-$9.35M
10-Q 2025-05-14
-$14.5M
10-Q 2026-05-14
-55.0%first · latest
Operating income
OperatingIncomeLoss
quarter 2025-03-31-$10.2M
10-Q 2025-05-14
-$15.3M
10-Q 2026-05-14
-50.5%first · latest
Net income
NetIncomeLoss
quarter 2024-12-31-$7.36M
10-Q 2025-02-14
-$9.55M
10-Q 2026-05-14
-29.8%first · latest · 4 filings carry it
Operating income
OperatingIncomeLoss
quarter 2024-12-31-$8.61M
10-Q 2025-02-14
-$10.8M
10-Q 2026-02-12
-25.5%first · latest

2 share-count periods re-presented for a stock split (7-for-1) are listed apart from restatements and not counted above.

First filing reporting each period vs the latest filing carrying it (10-K and 10-Q only, periods since 2020, the extractor's winning tag per concept); a change under 0.5% is treated as rounding; share counts re-presented by an integer split ratio are listed as split adjustments, not restatements. A change can be a restatement, a reclassification or a re-tagging in a later comparative column; the two filings are linked so the reader can see which. Descriptive, not a verdict.

Notes by disclosure type

debt, leases, revenue, segments, contingencies, taxes and more · the filer's own words
Latest annual report10-K FY2025 · filed 20250922View filing
Commitments and contingencies · 690 characters as filed

1 2 . Commitments and contingencies Contract commitments The Company enters into contracts in the normal course of business with third-party contract research organizations, contract development and manufacturing organizations and other service providers and vendors. These contracts generally provide for termination on notice and, therefore, are cancellable contracts and not considered contractual obligations and commitments. Contingencies From time to time, the Company may become subject to claims and litigation arising in the ordinary course of business. The Company is not a party to any material legal proceedings, nor is it aware of any material pending or threatened litigation.

CommitmentsAndContingenciesDisclosureTextBlock

Income taxes · 6,343 characters as filed

1 1 . Income taxes Loss before provision for incom e taxes cons isted of the following: (US$000) Year Ended June 30, 2025 2024 United States $ (37,183 ) $ (21,036 ) International (734 ) (715 ) Total $ (37,917 ) $ (21,751 ) The tax effects of significant items comprising the Companys deferred taxes are as follows: (US$000) June 30, 2025 2024 Deferred tax assets: Net operating losses $ 16,473 $ 14,466 Other 110 172 Lease liability 178 60 Share-based compensation 470 264 Intangible assets 200 218 Section 174 Capitalization 8,103 5,771 Gross deferred tax assets 25,534 20,951 Less valuation allowance (25,044 ) (20,594 ) Deferred tax liabilities: Right-of-use assets (181 ) (57 ) Fixed assets (5 ) (5 ) Prepaid expenses (123 ) (99 ) Unrealized foreign exchange gains and losses (181 ) (196 ) Total deferred tax liabilities (490 ) (357 ) Net deferred taxes $ $ ASC 740 requires that the tax benefit of net operating losses, temporary differences and credit carryforwards be recorded as an asset to the extent that management assesses that realization is more likely than not. Realization of the future tax benefits is dependent on the Companys ability to generate sufficient taxable income within the carryforward period. Because of the Companys recent history of operating losses, management believes that recognition of the deferred tax assets arising from the above-mentioned future tax benefits is currently not likely to be realized and, accordingly, has provided a valuation allowance. As of J

IncomeTaxDisclosureTextBlock · excerpt; the full note is in the filing

Leases · 2,699 characters as filed

9 . Leases The Company has entered into two operating leases for office spaces as of June 30, 2025. On February 1, 2025, the Company entered into a new lease which has an initial expiration date in 2026. On February 24, 2025, the Company entered into an amendment to an existing lease to extend the lease expiration date to 2027 and modify the remaining lease payments. The lease modification was not accounted for as a separate contract and instead the existing operating lease right-of-use asset and liability were remeasured during the period under agreements that expire in 2026 and 2027. Both leases contain options to extend for additional renewal periods. The leases require the Company to pay utilities, insurance, taxes, and other operating expenses. The Companys lease does not contain any residual value guarantees or material restrictive covenants. The tables below show the changes during the year ended June 30, 2025: (US$000) Operating lease right- of- use assets Balance at July 1, 2024 $ 270 Re-measurement during the period 666 Initial measurement at February 1, 2025 254 Amortization of right of use asset (330 ) Operating lease right-of-use asset at June 30, 2025 $ 860 (US$000) Operating lease liabilities Balance at July 1, 2024 $ 284 Re-measurement during the period 666 Initial measurement at February 1, 2025 255 Principal payments on operating lease liabilities (356 ) Operating lease liabilities at June 30 2025 849 Less: non-current portion (495 ) Current portion at June

LesseeOperatingLeasesTextBlock · excerpt; the full note is in the filing

New accounting pronouncements · 615 characters as filed

Recent Accounting Pronouncements In November 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standard Update (ASU) No. 2023-07, Segment Reporting (Topic 280) Improvements to Reportable Segment Disclosures , which requires disclosures about significant segment expenses and additional interim disclosure requirements. The standard also requires a single reportable segment company to provide all disclosures required by Topic 280. The Company adopted ASU 2023-07 during the year ended June 30, 2025. See Note 13 for the segment disclosures as required by Topic 280, as amended by ASU 2023-07.

NewAccountingPronouncementsPolicyPolicyTextBlock

Related parties · 6,796 characters as filed

1 4 . Related party transactions During the years ended June 30, 2025 and 2024, the Company did not enter into any related party transactions other than as set forth below or equity and other compensation, termination, change in control and other arrangements, which are described or incorporated by reference in Part III of this Annual Report on Form 10-K. On August 11, 2023, we closed an underwritten public offering of common stock and pre-funded warrants (the 2023 Pre-Funded Warrants) and common warrants (the 2023 Common Warrants) that were purchased together with the common stock and the 2023 Pre-Funded Warrants (the 2023 Offering). We sold an aggregate of 875,949 shares of common stock and 15,126,226 of 2023 Pre-Funded Warrants exercisable for shares of our common stock at an exercise price of $0.0001 per share, and 16,002,175 of 2023 Common Warrants exercisable for shares of our common stock at an exercise price of $3.86 per share in the 2023 Offering. The net proceeds to us from the 2023 Offering were approximately $28.6 million, after deducting underwriting discounts and commissions and estimated 2023 Offering expenses payable by us, and excluding any proceeds we may receive upon exercise of the 2023 Pre-Funded Warrants or the 2023 Common Warrants. Entities affiliated with Suvretta, Franklin Resources and Janus Henderson Group plc, each a beneficial owner of more than five percent of the outstanding shares of our common stock, participated in the offering on the same te

RelatedPartyTransactionsDisclosureTextBlock · excerpt; the full note is in the filing

Segment reporting · 1,891 characters as filed

1 3 . Segment reporting The Companys operating segments are components of the Company for which separate discrete financial information is available and is evaluated by the Companys chief operating decision maker (CODM), the Chief Executive Officer , in deciding how to allocate resources and assess performance. The Companys CODM views the Companys operations and manages its business as a single reportable segment with a single operating segment, which is the business of discovery and development of therapeutic agents in the treatment of genetic disorders. While the Company has subsidiaries in several geographic regions, there are no standalone operations; rather, all R&D activities are supported by a single corporate team. The determination of a single reportable segment is consistent with the consolidated financial information available and regularly reviewed by the Companys CODM. The Company manages R&D activities and operating expenses on a consolidated basis. The CODM uses comprehensive net loss in making decisions regarding resource allocation and evaluating financial performance, which is also reported on the consolidated statements of operations and comprehensive loss. The measure of segment assets is reported on the consolidated balance sheets as total assets. The following table represents the potential format for reporting the results of the Companys reportable segment for the year ending June 30, 2025: (US$000) Fiscal Year Ended June 30, Operating Expenses

SegmentReportingDisclosureTextBlock · excerpt; the full note is in the filing

Significant accounting policies · 22,193 characters as filed

2. Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation The Companys consolidated financial statements contained in this report have been prepared in accordance with generally accepted accounting principles in the U.S. (GAAP) and pursuant to the rules and regulations of the SEC. Reference is frequently made herein to the Financial Accounting Standards Board (the FASB) Accounting Standards Codification (ASC). This is the source of authoritative GAAP recognized by the FASB to be applied to non-governmental entities. Principles of Consolidation The consolidated financial statements include the Companys accounts and the accounts of its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated. Use of Estimates The preparation of the Companys consolidated financial statements requires management to make estimates and assumptions that impact the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in the Companys consolidated financial statements and accompanying notes. The most significant estimates and assumptions in the Companys consolidated financial statements relate to accrued research and development expense and valuation of equity-based instruments issued for other than cash. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of wh

SignificantAccountingPoliciesTextBlock · excerpt; the full note is in the filing

Stockholders' equity · 20,932 characters as filed

10 . Stockholders equity Preferred Stock On December 6, 2024, th e stockholders of the Company approved an amendment (the Amendment) to the Companys Amended and Restated Certificate of Incorporation, as amended, to authorize the issuance of 5,000,000 shares of preferred stock, par value $ 0.0001 . As of June 30, 2025, there were no preferred shares issued and outstanding. Common Stock On December 8, 2021, the stockholders of the Company approved an amendment (the Charter Amendment) to the Companys Amended and Restated Certificate of Incorporation to increase the total number of authorized shares of common stock of the Company from 10,000,000 to 40,000,000, which became effective on December 17, 2021. On December 7, 2022, the stockholders of the Company approved another amendment to the Companys Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 40,000,000 to 160,000,000. The Charter Amendment was filed with the Secretary of State of the State of Delaware and became effective December 9, 2022. On July 26, 2023, the Company effected a 1-for-17 reverse stock split (the Reverse Stock Split). On October 11, 2024, the Company entered into a Sales Agreement (the Sales Agreement) with Leerink Partners LLC (the Agent). Pursuant to the terms of the Sales Agreement, the Company may offer and sell shares of the Companys common stock having an aggregate offering amount of up to $75 million from time to time through the Agent.

StockholdersEquityNoteDisclosureTextBlock · excerpt; the full note is in the filing

Subsequent events · 29 characters as filed

1 5 . Subsequent events None.

SubsequentEventsTextBlock

Source: SEC DERA Financial Statement and Notes data sets (txt.tsv), excerpts of the filer's own note text; the full note is in the linked filing. Excerpts are the first part of each note exactly as tagged in the filing; open the filing for the full text and the tables. Descriptive and educational, not advice.

Fundamentals from SEC EDGAR. Scores, the DCF, and every model shown are educational analysis, not investment advice or price predictions.

Educational content only. Not financial advice. TrendNalysis provides educational and informational financial analysis built from public SEC filings and economic data (FRED, BLS). It is not financial, investment, tax, or legal advice and is not a recommendation to buy or sell any security. Market pricing is not currently included. Past performance does not guarantee future results. Always do your own research and consult a licensed financial professional before investing.